7-benzylamino-6-chloro-2-piperazino-4-pyrrolidinopteridine has been researched along with bucladesine in 1 studies
| Studies (7-benzylamino-6-chloro-2-piperazino-4-pyrrolidinopteridine) | Trials (7-benzylamino-6-chloro-2-piperazino-4-pyrrolidinopteridine) | Recent Studies (post-2010) (7-benzylamino-6-chloro-2-piperazino-4-pyrrolidinopteridine) | Studies (bucladesine) | Trials (bucladesine) | Recent Studies (post-2010) (bucladesine) |
|---|---|---|---|---|---|
| 10 | 0 | 1 | 9,775 | 13 | 210 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho-Chung, YS; Eisenbrand, G; Habermeyer, M; Hippe, F; Jakobs, S; Marko, D; Wagner, B | 1 |
1 other study(ies) available for 7-benzylamino-6-chloro-2-piperazino-4-pyrrolidinopteridine and bucladesine
| Article | Year |
|---|---|
7-Benzylamino-6-chloro-2-piperazino-4-pyrrolidino-pteridine, a potent inhibitor of cAMP-specific phosphodiesterase, enhancing nuclear protein binding to the CRE consensus sequence in human tumour cells.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Bucladesine; Consensus Sequence; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 4; DNA; Humans; Isoenzymes; Nuclear Proteins; Phosphodiesterase Inhibitors; Piperazines; Pteridines; Tumor Cells, Cultured | 2002 |